Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative intravesical mitomycin to reduce bladder recurrence after surgery for upper urinary tract urothelial carcinoma
NL-OMON50424Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mitomycin c in upper tract urothelial carcinoma (UTUC) (2 arms), sponsored by Erasmus MC. Started Nov 2017; status: active, not recruiting.
02
Drugs
mitomycin c
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NL-OMON50424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50424.